7,338 followers
Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide | Experimental Hematology & Oncology | Full Text https://t.co/eUI9lW8lUr #lymphoma @lymphomahub